Vaccinex, Inc. (OTC: VCNX) ("Vaccinex" or the "Company"), a clinical-stage biotechnology company pioneering a differentiated approach to treating neurodegenerative ...

Vaccinex intends to file a Form 25 with the Securities and Exchange Commission on or about March 17, 2025 to remove its Common Stock from listing on Nasdaq.

Q4 2024 Results Conference Call March 6, 2025 8:00 AM ETCompany ParticipantsFlorian Schraeder - Head of Investor ...

FRANKFURT (Reuters) - Merck KGaA on Thursday forecast currency-adjusted operating earnings growth of up to 8%, helped by ...

Wiley (NYSE: WLY) has announced the appointment of Karen N. Madden, Ph.D., as a new member of its board of directors. Dr.

MilliporeSigma Chief Technology Officer Brings Extensive Science, Technology, and Innovation Leadership Experience Wiley (NYSE: WLY), one of the world's largest publishers and a trusted leader in ...

Wiley (NYSE: WLY), one of the world's largest publishers and a trusted leader in research and learning, today announced the appointment of Karen N. Madden, Ph.D., to its Board of Directors. Madden is ...

Q4 2024 Earnings Call Transcript February 28, 2025 Rapid Micro Biosystems, Inc. reports earnings inline with expectations.

Announced positive initial Phase 1 clinical data and an additional Fast Track designation for Emi-LeInitiated first expansion cohort in patients ...